Syndax Announces Participation at Three Upcoming Investor Conferences

Rhea-AI Summary

Syndax Pharmaceuticals, a clinical stage biopharmaceutical company, announced its participation in three virtual investor conferences. The events include a fireside chat at the Morgan Stanley Global Healthcare Conference on September 9, 2021, a panel at the Citi BioPharma Virtual Conference on September 10, and another fireside chat at the Baird Global Healthcare Conference on September 14. Investors can access a live webcast of the first two events and find replays on the company's website. Syndax is developing innovative cancer therapies, including SNDX-5613 and axatilimab.

WALTHAM, Mass., Sept. 2, 2021 /PRNewswire/ -- Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that members of its management team will participate in three upcoming virtual investor conferences:

• A fireside chat at the Morgan Stanley 19th Annual Global Healthcare Conference at 9:30 a.m. ET on Thursday, September 9, 2021.
• A panel at the Citi 16th Annual BioPharma Virtual Conference at 9:45 a.m. ET on Friday, September 10, 2021.
• A fireside chat at the Baird Global Healthcare Conference at 8:30 a.m. ET on Tuesday, September 14, 2021.

A live webcast of the Morgan Stanley presentation and Citi panel can be accessed from the Investor section of the Company's website at www.syndax.com, where a replay of the events will also be available for a limited time.

About Syndax Pharmaceuticals, Inc.

Syndax Pharmaceuticals is a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies. The Company's pipeline includes SNDX-5613, a highly selective inhibitor of the Menin–MLL binding interaction, axatilimab, a monoclonal antibody that blocks the colony stimulating factor 1 (CSF-1) receptor, and entinostat, a class I HDAC inhibitor. For more information, please visit  www.syndax.com or follow the Company on Twitter and LinkedIn. 

Syndax Contacts

Investor Contact
Melissa Forst
Argot Partners
melissa@argotpartners.com
Tel 212.600.1902

Media Contact
Ted Held
ted.held@gcihealth.com
Tel 212.798.9842

SNDX-G

 

View original content:https://www.prnewswire.com/news-releases/syndax-announces-participation-at-three-upcoming-investor-conferences-301368070.html

SOURCE Syndax Pharmaceuticals, Inc.

FAQ

When is Syndax Pharmaceuticals participating in investor conferences?

Syndax Pharmaceuticals will participate in three virtual investor conferences: Morgan Stanley on September 9, Citi on September 10, and Baird on September 14, 2021.

What is the stock symbol for Syndax Pharmaceuticals?

The stock symbol for Syndax Pharmaceuticals is SNDX.

Where can I watch the live webcast of Syndax's investor conferences?

The live webcast of Syndax's investor conferences can be accessed from the Investor section of their website at www.syndax.com.

What types of therapies is Syndax Pharmaceuticals developing?

Syndax is developing an innovative pipeline of cancer therapies, including SNDX-5613, axatilimab, and entinostat.

What time will the fireside chat at the Morgan Stanley conference start?

The fireside chat at the Morgan Stanley conference is scheduled to start at 9:30 a.m. ET on September 9, 2021.